165 related articles for article (PubMed ID: 9580885)
21. Roles of the envelope proteins in the amplification of covalently closed circular DNA and completion of synthesis of the plus-strand DNA in hepatitis B virus.
Lentz TB; Loeb DD
J Virol; 2011 Nov; 85(22):11916-27. PubMed ID: 21900164
[TBL] [Abstract][Full Text] [Related]
22. [Specific degradation of nuclear hepatitis B virus covalently closed circular DNA].
Lucifora J; Xia Y; Reisinger F; Stadler D; Heikenwälder M; Protzer U
Med Sci (Paris); 2014; 30(8-9):724-6. PubMed ID: 25174742
[No Abstract] [Full Text] [Related]
23. Core components of DNA lagging strand synthesis machinery are essential for hepatitis B virus cccDNA formation.
Wei L; Ploss A
Nat Microbiol; 2020 May; 5(5):715-726. PubMed ID: 32152586
[TBL] [Abstract][Full Text] [Related]
24. Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo.
Allweiss L; Volz T; Giersch K; Kah J; Raffa G; Petersen J; Lohse AW; Beninati C; Pollicino T; Urban S; Lütgehetmann M; Dandri M
Gut; 2018 Mar; 67(3):542-552. PubMed ID: 28428345
[TBL] [Abstract][Full Text] [Related]
25. Recombinant covalently closed circular hepatitis B virus DNA induces prolonged viral persistence in immunocompetent mice.
Qi Z; Li G; Hu H; Yang C; Zhang X; Leng Q; Xie Y; Yu D; Zhang X; Gao Y; Lan K; Deng Q
J Virol; 2014 Jul; 88(14):8045-56. PubMed ID: 24807718
[TBL] [Abstract][Full Text] [Related]
26. In vivo proliferation of hepadnavirus-infected hepatocytes induces loss of covalently closed circular DNA in mice.
Lutgehetmann M; Volz T; Köpke A; Broja T; Tigges E; Lohse AW; Fuchs E; Murray JM; Petersen J; Dandri M
Hepatology; 2010 Jul; 52(1):16-24. PubMed ID: 20578126
[TBL] [Abstract][Full Text] [Related]
27. Asymmetric Modification of Hepatitis B Virus (HBV) Genomes by an Endogenous Cytidine Deaminase inside HBV Cores Informs a Model of Reverse Transcription.
Nair S; Zlotnick A
J Virol; 2018 May; 92(10):. PubMed ID: 29491156
[TBL] [Abstract][Full Text] [Related]
28. Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine.
Bowden S; Locarnini S; Chang TT; Chao YC; Han KH; Gish RG; de Man RA; Yu M; Llamoso C; Tang H
World J Gastroenterol; 2015 Apr; 21(15):4644-51. PubMed ID: 25914474
[TBL] [Abstract][Full Text] [Related]
29. A Role for the Host DNA Damage Response in Hepatitis B Virus cccDNA Formation-and Beyond?
Schreiner S; Nassal M
Viruses; 2017 May; 9(5):. PubMed ID: 28531167
[TBL] [Abstract][Full Text] [Related]
30. Formation of covalently closed circular DNA in Hep38.7-Tet cells, a tetracycline inducible hepatitis B virus expression cell line.
Ogura N; Watashi K; Noguchi T; Wakita T
Biochem Biophys Res Commun; 2014 Sep; 452(3):315-21. PubMed ID: 25150444
[TBL] [Abstract][Full Text] [Related]
31. n-Butyrate, a cell cycle blocker, inhibits early amplification of duck hepatitis B virus covalently closed circular DNA after in vitro infection of duck hepatocytes.
Turin F; Borel C; Benchaib M; Kay A; Jamard C; Guguen-Guillouzo C; Trépo C; Hantz O
J Virol; 1996 May; 70(5):2691-6. PubMed ID: 8627742
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones.
Pollicino T; Belloni L; Raffa G; Pediconi N; Squadrito G; Raimondo G; Levrero M
Gastroenterology; 2006 Mar; 130(3):823-37. PubMed ID: 16530522
[TBL] [Abstract][Full Text] [Related]
33. Dynamics of HBV cccDNA expression and transcription in different cell growth phase.
Chong CL; Chen ML; Wu YC; Tsai KN; Huang CC; Hu CP; Jeng KS; Chou YC; Chang C
J Biomed Sci; 2011 Dec; 18(1):96. PubMed ID: 22208719
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B Virus Covalently Closed Circular DNA Formation in Immortalized Mouse Hepatocytes Associated with Nucleocapsid Destabilization.
Cui X; Guo JT; Hu J
J Virol; 2015 Sep; 89(17):9021-8. PubMed ID: 26085156
[TBL] [Abstract][Full Text] [Related]
35. Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication.
Dong C; Qu L; Wang H; Wei L; Dong Y; Xiong S
Antiviral Res; 2015 Jun; 118():110-7. PubMed ID: 25843425
[TBL] [Abstract][Full Text] [Related]
36. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell.
Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX
Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501
[TBL] [Abstract][Full Text] [Related]
37. Viral DNA-Dependent Induction of Innate Immune Response to Hepatitis B Virus in Immortalized Mouse Hepatocytes.
Cui X; Clark DN; Liu K; Xu XD; Guo JT; Hu J
J Virol; 2016 Jan; 90(1):486-96. PubMed ID: 26491170
[TBL] [Abstract][Full Text] [Related]
38. The Role of cccDNA in HBV Maintenance.
Allweiss L; Dandri M
Viruses; 2017 Jun; 9(6):. PubMed ID: 28635668
[TBL] [Abstract][Full Text] [Related]
39. Quantitation of hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) in the liver of HBV-infected patients by LightCycler real-time PCR.
Singh M; Dicaire A; Wakil AE; Luscombe C; Sacks SL
J Virol Methods; 2004 Jun; 118(2):159-67. PubMed ID: 15081611
[TBL] [Abstract][Full Text] [Related]
40. [Small Molecular Inhibitors of DNA Double Strand Break Repair Pathways Increase the ANTI-HBV Activity of CRISPR/Cas9].
Kostyusheva AP; Kostyushev DS; Brezgin SA; Zarifyan DN; Volchkova EV; Chulanov VP
Mol Biol (Mosk); 2019; 53(2):311-323. PubMed ID: 31099781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
